AP
AGN

Arlington Partners’s Allergan plc AGN Stock Holding History

Arlington Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-17
Closed -$3K – 321
2020
Q1 		$3K Buy
+17
New +$3.2K ﹤0.01% 236
2019
Q2 		– Sell
-675
Closed -$99K – 264
2019
Q1 		$99K Buy
+675
New +$97.9K 0.07% 101

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Arlington Partners's AGN Position: Q2 2020 in Review

Arlington Partners sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 17 shares — an estimated $3K sold.

Arlington Partners first reported a position in AGN in Q1 2019 and held it in 2 quarters. The position peaked at $99K in Q1 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Arlington Partners reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Arlington Partners sold 17 Allergan plc shares in Q2 2020, an estimated $3K.
  • Arlington Partners first reported a position in Allergan plc in Q1 2019 and held it in 2 quarters.
  • Arlington Partners's Allergan plc position peaked at $99K in Q1 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Arlington Partners's 13F filing for Q2 2020, filed 13 Jul 2020.